Giles Robinson
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Giles Robinson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01878617 · A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaSt. Jude Children's Research Hospital · active not recruiting · Medulloblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Neurobiology and Brain Tumor ProgramP30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2025 · $64,171 awarded in 2025Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission)R01CA187079 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HEATHER M CONKLIN · fiscal years 2015 to 2019Named on NCT01878617
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:00 UTC. The ranking covers the 200 most relevant of 77 PubMed records, and a shared surname and initials can bring in a namesake. All 77 on PubMed
- 339 citationsRCR 9.4
- Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.Thorax · 2004252 citationsRCR 7.0
- Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients.Eur Respir J · 2006233 citationsRCR 6.8
- Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.Lancet Oncol · 2018208 citationsRCR 7.1
- 205 citationsRCR 6.8
- Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).J Clin Oncol · 2021201 citationsRCR 11.3
- A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors.Clin Cancer Res · 2017152 citationsRCR 4.4
- Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).Neuro Oncol · 2022117 citationsRCR 8.2
- 83 citationsRCR 6.3
- Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.Neuro Oncol · 201980 citationsRCR 3.5